SIMILAR PATTERNS OF AMINO ACIDS FOR 4N09_D_ADND401
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b0k | PROTEIN (ACONITASE) (Sus scrofa) |
PF00330(Aconitase)PF00694(Aconitase_C) | 5 | ASP A 454GLY A 451ALA A 461PHE A 326GLY A 436 | None | 0.96A | 4n09D-1b0kA:undetectable | 4n09D-1b0kA:19.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dgm | ADENOSINE KINASE (Toxoplasmagondii) |
PF00294(PfkB) | 7 | ASN A 20ASP A 24GLY A 68GLY A 69ASN A 73GLY A 315ASP A 318 | ADN A 375 ( 3.8A)ADN A 375 (-2.9A)ADN A 375 ( 4.5A)ADN A 375 (-2.9A)ADN A 375 ( 4.9A)ACY A 370 (-3.1A)ADN A 375 ( 3.1A) | 0.48A | 4n09D-1dgmA:41.5 | 4n09D-1dgmA:34.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dgm | ADENOSINE KINASE (Toxoplasmagondii) |
PF00294(PfkB) | 8 | ASP A 24LEU A 46GLY A 68GLY A 69ASN A 73CYH A 127GLY A 315ASP A 318 | ADN A 375 (-2.9A)NoneADN A 375 ( 4.5A)ADN A 375 (-2.9A)ADN A 375 ( 4.9A)ADN A 375 ( 4.2A)ACY A 370 (-3.1A)ADN A 375 ( 3.1A) | 0.61A | 4n09D-1dgmA:41.5 | 4n09D-1dgmA:34.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1geu | GLUTATHIONEREDUCTASE (Escherichiacoli) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 6 | LEU A 334GLY A 16GLY A 15ALA A 317ASN A 304GLY A 140 | NoneNoneFAD A 451 (-3.5A)NoneNoneFAD A 451 (-3.5A) | 1.02A | 4n09D-1geuA:4.9 | 4n09D-1geuA:22.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rk2 | RIBOKINASE (Escherichiacoli) |
PF00294(PfkB) | 5 | ASP A 16GLY A 41GLY A 42ASN A 46ASP A 255 | RIB A 311 (-2.8A)RIB A 311 (-3.3A)RIB A 311 (-3.4A)RIB A 311 (-3.3A)RIB A 311 (-3.1A) | 0.35A | 4n09D-1rk2A:33.3 | 4n09D-1rk2A:26.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tz6 | PUTATIVE SUGARKINASE (Salmonellaenterica) |
PF00294(PfkB) | 6 | ASP A 16GLY A 30GLY A 31ASN A 35GLY A 249ASP A 252 | AIS A 402 (-2.5A)AIS A 402 ( 4.2A)AIS A 402 (-3.8A)AIS A 402 (-3.9A)AIS A 402 ( 4.5A)AIS A 402 (-3.0A) | 0.54A | 4n09D-1tz6A:30.5 | 4n09D-1tz6A:24.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v19 | 2-KETO-3-DEOXYGLUCONATE KINASE (Thermusthermophilus) |
PF00294(PfkB) | 6 | LEU A 170GLY A 33GLY A 34ASN A 38GLY A 248ASP A 251 | None | 1.01A | 4n09D-1v19A:30.6 | 4n09D-1v19A:28.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vef | ACETYLORNITHINE/ACETYL-LYSINEAMINOTRANSFERASE (Thermusthermophilus) |
PF00202(Aminotran_3) | 5 | GLY A 257GLY A 294ALA A 69ASN A 287GLY A 286 | None | 0.95A | 4n09D-1vefA:3.2 | 4n09D-1vefA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vgp | 373AA LONGHYPOTHETICAL CITRATESYNTHASE (Sulfurisphaeratokodaii) |
PF00285(Citrate_synt) | 5 | LEU A 27GLY A 216GLY A 217ASN A 219GLY A 251 | None | 0.91A | 4n09D-1vgpA:undetectable | 4n09D-1vgpA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vm7 | RIBOKINASE (Thermotogamaritima) |
PF00294(PfkB) | 5 | ASP A 14GLY A 39GLY A 40ASN A 44ASP A 246 | None | 0.57A | 4n09D-1vm7A:31.8 | 4n09D-1vm7A:26.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2abq | FRUCTOSE 1-PHOSPHATEKINASE (Bacillushalodurans) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 246ASP A 249 | None | 1.17A | 4n09D-2abqA:26.5 | 4n09D-2abqA:24.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2afb | 2-KETO-3-DEOXYGLUCONATE KINASE (Thermotogamaritima) |
PF00294(PfkB) | 6 | LEU A 171GLY A 32GLY A 33ASN A 37GLY A 277ASP A 280 | None | 1.07A | 4n09D-2afbA:30.6 | 4n09D-2afbA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ajr | SUGAR KINASE, PFKBFAMILY (Thermotogamaritima) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 39GLY A 40ASN A 44GLY A 258ASP A 261 | NoneACT A 321 (-3.1A)ACT A 321 ( 4.3A)ACT A 321 (-3.9A)ACT A 321 (-3.9A)NoneNone | 1.04A | 4n09D-2ajrA:25.5 | 4n09D-2ajrA:25.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c49 | SUGAR KINASE MJ0406 (Methanocaldococcusjannaschii) |
PF00294(PfkB) | 6 | ASP A 17GLY A 42GLY A 43ASN A 47GLY A 244ASP A 247 | ADN A1301 (-2.8A)ADN A1301 (-3.4A)ADN A1301 (-3.3A)ADN A1301 (-3.4A)NoneADN A1301 (-2.9A) | 0.77A | 4n09D-2c49A:29.5 | 4n09D-2c49A:25.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f02 | TAGATOSE-6-PHOSPHATEKINASE (Enterococcusfaecalis) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 252ASP A 255 | NoneNoneNoneNoneNoneATP A 411 (-3.6A)ATP A 411 (-4.1A) | 1.07A | 4n09D-2f02A:26.2 | 4n09D-2f02A:25.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 8 | ASN A 14ASP A 18GLY A 63GLY A 64ASN A 68CYH A 123GLY A 297ASP A 300 | 89I A 500 (-4.0A)NoneNone89I A 500 (-3.5A)NoneNoneNoneNone | 0.67A | 4n09D-2i6bA:42.8 | 4n09D-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 7 | ASN A 14GLY A 63GLY A 64ASN A 68PHE A 170GLY A 297ASP A 300 | 89I A 500 (-4.0A)None89I A 500 (-3.5A)None89I A 500 (-3.8A)NoneNone | 0.54A | 4n09D-2i6bA:42.8 | 4n09D-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 9 | ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68CYH A 123ALA A 136GLY A 297ASP A 300 | None89I A 500 ( 4.8A)None89I A 500 (-3.5A)NoneNone89I A 500 (-3.4A)NoneNone | 0.67A | 4n09D-2i6bA:42.8 | 4n09D-2i6bA:40.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2i6b | ADENOSINE KINASE (Homo sapiens) |
PF00294(PfkB) | 6 | LEU A 40GLY A 64ASN A 68CYH A 123ALA A 136GLY A 297 | 89I A 500 ( 4.8A)89I A 500 (-3.5A)NoneNone89I A 500 (-3.4A)None | 1.33A | 4n09D-2i6bA:42.8 | 4n09D-2i6bA:40.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i6x | HYDROLASE, HALOACIDDEHALOGENASE-LIKEFAMILY (Porphyromonasgingivalis) |
PF13419(HAD_2) | 5 | ASP A 172LEU A 37GLY A 11GLY A 10ASN A 176 | None | 0.85A | 4n09D-2i6xA:4.1 | 4n09D-2i6xA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ibu | ACETYL-COAACETYLTRANSFERASE (Homo sapiens) |
PF00108(Thiolase_N)PF02803(Thiolase_C) | 5 | ASN A 158LEU A 67GLY A 97ALA A 64GLY A 183 | None | 1.00A | 4n09D-2ibuA:undetectable | 4n09D-2ibuA:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ify | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Bacillusanthracis) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ASP A 402GLY A 12GLY A 445ALA A 460GLY A 64 | MN A 601 (-2.4A)NoneNoneNoneNone | 0.84A | 4n09D-2ifyA:5.0 | 4n09D-2ifyA:21.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jg5 | FRUCTOSE 1-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 36GLY A 37ASN A 41GLY A 246ASP A 249 | None | 1.19A | 4n09D-2jg5A:25.9 | 4n09D-2jg5A:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgv | TAGATOSE-6-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | ASP A 12GLY A 36GLY A 37ASN A 41ASP A 254 | None | 0.86A | 4n09D-2jgvA:25.7 | 4n09D-2jgvA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgv | TAGATOSE-6-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | ASP A 12GLY A 36GLY A 37ASN A 41CYH A 90 | None | 0.99A | 4n09D-2jgvA:25.7 | 4n09D-2jgvA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jgv | TAGATOSE-6-PHOSPHATEKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | GLY A 36GLY A 37ASN A 41GLY A 251ASP A 254 | None | 0.71A | 4n09D-2jgvA:25.7 | 4n09D-2jgvA:22.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nwh | CARBOHYDRATE KINASE (Agrobacteriumfabrum) |
PF00294(PfkB) | 5 | ASP A 13GLY A 37GLY A 38ASN A 42ASP A 253 | NoneNone CL A 403 (-3.5A)NoneNone | 0.97A | 4n09D-2nwhA:26.3 | 4n09D-2nwhA:27.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qcv | PUTATIVE5-DEHYDRO-2-DEOXYGLUCONOKINASE (Bacillushalodurans) |
PF00294(PfkB) | 6 | ASP A 22GLY A 43GLY A 44ASN A 48GLY A 269ASP A 272 | NoneNoneNoneNoneNonePGE A 332 (-3.6A) | 0.56A | 4n09D-2qcvA:30.9 | 4n09D-2qcvA:24.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vaw | CELL DIVISIONPROTEIN FTSZ (Pseudomonasaeruginosa) |
PF00091(Tubulin)PF12327(FtsZ_C) | 5 | LEU A 83GLY A 20GLY A 110ALA A 82GLY A 72 | NoneGDP A1317 (-3.4A)GDP A1317 (-3.2A)NoneNone | 0.96A | 4n09D-2vawA:8.6 | 4n09D-2vawA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z8z | LIPASE (Pseudomonas sp.MIS38) |
PF00353(HemolysinCabind) | 5 | ASN A 441GLY A 403ASN A 405GLY A 382ASP A 400 | None CA A 621 ( 4.7A) CA A 621 (-2.8A) CA A 621 ( 4.8A) CA A 621 (-2.3A) | 0.96A | 4n09D-2z8zA:undetectable | 4n09D-2z8zA:20.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a8u | OMEGA-AMINOACID--PYRUVATEAMINOTRANSFERASE (Pseudomonasputida) |
PF00202(Aminotran_3) | 5 | LEU X 186GLY X 416GLY X 417ASN X 168GLY X 167 | None | 0.99A | 4n09D-3a8uX:undetectable | 4n09D-3a8uX:25.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3czm | L-LACTATEDEHYDROGENASE (Toxoplasmagondii) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | ASP A 143GLY A 288GLY A 193ASN A 165ASP A 168 | None | 0.99A | 4n09D-3czmA:5.9 | 4n09D-3czmA:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ewm | UNCHARACTERIZEDSUGAR KINASE PH1459 (Pyrococcushorikoshii) |
PF00294(PfkB) | 7 | ASP A 13LEU A 167GLY A 33GLY A 34ASN A 38GLY A 244ASP A 247 | None | 1.05A | 4n09D-3ewmA:29.7 | 4n09D-3ewmA:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3go7 | RIBOKINASE RBSK (Mycobacteriumtuberculosis) |
PF00294(PfkB) | 6 | ASP A 25GLY A 50GLY A 51ASN A 55GLY A 239ASP A 242 | RIB A 305 (-2.8A)RIB A 305 ( 3.7A)RIB A 305 (-3.1A)RIB A 305 (-3.2A)RIB A 305 ( 4.5A)RIB A 305 (-2.9A) | 0.54A | 4n09D-3go7A:28.7 | 4n09D-3go7A:27.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hj6 | FRUCTOKINASE (Halothermothrixorenii) |
PF00294(PfkB) | 6 | ASP A 33LEU A 188GLY A 54GLY A 55ASN A 59ASP A 275 | None | 0.80A | 4n09D-3hj6A:28.3 | 4n09D-3hj6A:24.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i3y | CARBOHYDRATE KINASE (Klebsiellapneumoniae) |
PF00294(PfkB) | 6 | ASP A 12GLY A 37GLY A 38ASN A 42GLY A 229ASP A 232 | None | 0.84A | 4n09D-3i3yA:26.1 | 4n09D-3i3yA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3in1 | UNCHARACTERIZEDSUGAR KINASE YDJH (Escherichiacoli) |
PF00294(PfkB) | 6 | ASP A 15GLY A 41GLY A 42ASN A 46GLY A 257ASP A 260 | NoneNoneNoneNone NA A 411 ( 4.9A)None | 0.73A | 4n09D-3in1A:31.1 | 4n09D-3in1A:26.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ive | NUCLEOTIDASE (Escherichiacoli) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 373GLY A 372ASN A 370GLY A 471ASP A 472 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)NoneCTN A 603 (-2.7A) | 0.98A | 4n09D-3iveA:undetectable | 4n09D-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jty | BENF-LIKE PORIN (Pseudomonasprotegens) |
PF03573(OprD) | 5 | GLY A 312GLY A 311ALA A 321GLY A 153ASP A 151 | None | 0.96A | 4n09D-3jtyA:undetectable | 4n09D-3jtyA:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kfu | GLUTAMYL-TRNA(GLN)AMIDOTRANSFERASESUBUNIT A (Thermusthermophilus) |
PF01425(Amidase) | 5 | LEU E 106GLY E 143GLY E 144ALA E 64GLY E 79 | None | 0.96A | 4n09D-3kfuE:undetectable | 4n09D-3kfuE:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kzh | PROBABLE SUGARKINASE (Clostridiumperfringens) |
PF00294(PfkB) | 5 | GLY A 42GLY A 43ASN A 47GLY A 254ASP A 257 | None | 0.37A | 4n09D-3kzhA:28.1 | 4n09D-3kzhA:24.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3l44 | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE1 (Bacillusanthracis) |
PF00202(Aminotran_3) | 5 | GLY A 273GLY A 313ALA A 79ASN A 306GLY A 305 | LLP A 270 ( 4.0A)NoneNoneNoneNone | 0.81A | 4n09D-3l44A:undetectable | 4n09D-3l44A:22.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 11 | ASN A 14ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68CYH A 122ALA A 135PHE A 168GLY A 297ASP A 300 | B4P A 349 ( 4.0A)B4P A 349 (-2.8A)NoneB4P A 349 ( 3.8A)B4P A 349 (-3.5A)B4P A 349 (-3.6A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-3.4A)B4P A 349 (-2.9A)B4P A 349 (-3.4A) | 0.55A | 4n09D-3looA:47.9 | 4n09D-3looA:36.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 10 | ASN A 14LEU A 40GLY A 64ASN A 68CYH A 122ALA A 135PHE A 168ASN A 296GLY A 297ASP A 300 | B4P A 349 ( 4.0A)NoneB4P A 349 (-3.5A)B4P A 349 (-3.6A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-3.4A)B4P A 349 (-3.6A)B4P A 349 (-2.9A)B4P A 349 (-3.4A) | 0.91A | 4n09D-3looA:47.9 | 4n09D-3looA:36.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 7 | ASN A 14LEU A 40GLY A 64ASN A 68PHE A 168GLY A 299ASP A 300 | B4P A 349 ( 4.0A)NoneB4P A 349 (-3.5A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-3.3A)B4P A 349 (-3.4A) | 1.12A | 4n09D-3looA:47.9 | 4n09D-3looA:36.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 6 | GLY A 63ASN A 68CYH A 122ALA A 135GLY A 297ASP A 300 | B4P A 349 ( 3.8A)B4P A 349 (-3.6A)B4P A 349 (-3.6A)B4P A 349 (-3.4A)B4P A 349 (-2.9A)B4P A 349 (-3.4A) | 1.22A | 4n09D-3looA:47.9 | 4n09D-3looA:36.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mdq | EXOPOLYPHOSPHATASE (Cytophagahutchinsonii) |
PF02541(Ppx-GppA) | 5 | LEU A 61GLY A 40ALA A 57ASN A 89GLY A 87 | None | 0.99A | 4n09D-3mdqA:undetectable | 4n09D-3mdqA:23.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ngm | EXTRACELLULAR LIPASE (Fusariumgraminearum) |
PF01764(Lipase_3) | 5 | LEU A 157GLY A 63GLY A 64ALA A 153GLY A 19 | None | 0.99A | 4n09D-3ngmA:undetectable | 4n09D-3ngmA:19.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3noq | THIJ/PFPI FAMILYPROTEIN (Pseudomonasfluorescens) |
PF01965(DJ-1_PfpI) | 5 | GLY A 150GLY A 151ALA A 123GLY A 70ASP A 17 | NoneNoneNHE A 501 ( 4.4A)NHE A 501 ( 4.7A)EDO A 604 ( 4.6A) | 0.84A | 4n09D-3noqA:4.6 | 4n09D-3noqA:22.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 10 | ASN A 13ASP A 17LEU A 39GLY A 62GLY A 63ASN A 67CYH A 123ALA A 136PHE A 169ASP A 299 | AP5 A 346 (-4.1A)AP5 A 346 (-2.8A)NoneAP5 A 346 (-3.6A)AP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 (-3.7A)AP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 ( 3.2A) | 0.18A | 4n09D-3otxA:58.3 | 4n09D-3otxA:99.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 7 | ASN A 13LEU A 39GLY A 63ASN A 67PHE A 169GLY A 298ASP A 299 | AP5 A 346 (-4.1A)NoneAP5 A 346 (-3.5A)AP5 A 346 (-3.4A)AP5 A 346 (-3.4A)AP5 A 346 (-3.2A)AP5 A 346 ( 3.2A) | 1.06A | 4n09D-3otxA:58.3 | 4n09D-3otxA:99.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 7 | ASP A 17LEU A 39GLY A 62GLY A 63CYH A 123ALA A 136GLY A 296 | AP5 A 346 (-2.8A)NoneAP5 A 346 (-3.6A)AP5 A 346 (-3.5A)AP5 A 346 (-3.7A)AP5 A 346 (-3.5A)AP5 A 346 (-3.2A) | 0.64A | 4n09D-3otxA:58.3 | 4n09D-3otxA:99.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pl2 | SUGAR KINASE,RIBOKINASE FAMILY (Corynebacteriumglutamicum) |
PF00294(PfkB) | 6 | ASP A 19GLY A 40GLY A 41ASN A 45GLY A 261ASP A 264 | None | 0.60A | 4n09D-3pl2A:30.9 | 4n09D-3pl2A:26.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q1y | LIN2199 PROTEIN (Listeriainnocua) |
PF00294(PfkB) | 7 | ASN A 8ASP A 12GLY A 37GLY A 38CYH A 92GLY A 248ASP A 251 | None | 0.98A | 4n09D-3q1yA:26.1 | 4n09D-3q1yA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ry7 | RIBOKINASE (Staphylococcusaureus) |
PF00294(PfkB) | 5 | ASP A 14GLY A 40GLY A 41ASN A 45ASP A 254 | GOL A 401 (-3.1A)GOL A 401 ( 3.7A)GOL A 401 (-3.8A)GOL A 401 (-3.9A)None | 0.51A | 4n09D-3ry7A:29.2 | 4n09D-3ry7A:25.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3shw | TIGHT JUNCTIONPROTEIN ZO-1 (Homo sapiens) |
PF00595(PDZ)PF00625(Guanylate_kin)PF07653(SH3_2) | 5 | ASP A 517LEU A 487GLY A 516GLY A 439ALA A 483 | None | 0.97A | 4n09D-3shwA:undetectable | 4n09D-3shwA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tsw | TIGHT JUNCTIONPROTEIN ZO-1 (Homo sapiens) |
PF00595(PDZ)PF00625(Guanylate_kin)PF07653(SH3_2) | 5 | ASP A 517LEU A 487GLY A 516GLY A 439ALA A 483 | None | 0.99A | 4n09D-3tswA:undetectable | 4n09D-3tswA:25.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ubo | ADENOSINE KINASE (Sinorhizobiummeliloti) |
PF00294(PfkB) | 8 | ASN A 11ASP A 15LEU A 37GLY A 58GLY A 59ASN A 63GLY A 275ASP A 278 | ADN A 353 (-3.7A)ADN A 353 (-2.8A)NoneADN A 353 (-3.3A)ADN A 353 (-3.2A)ADN A 353 (-3.4A)ADN A 353 (-3.7A)ADN A 353 (-3.3A) | 0.65A | 4n09D-3uboA:39.5 | 4n09D-3uboA:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uqe | 6-PHOSPHOFRUCTOKINASE ISOZYME 2 (Escherichiacoli) |
PF00294(PfkB) | 5 | ASP A 14GLY A 38GLY A 39ASN A 43ASP A 256 | None | 0.76A | 4n09D-3uqeA:26.4 | 4n09D-3uqeA:24.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uqe | 6-PHOSPHOFRUCTOKINASE ISOZYME 2 (Escherichiacoli) |
PF00294(PfkB) | 5 | GLY A 38GLY A 39ASN A 43GLY A 253ASP A 256 | NoneNoneNoneATP A 401 ( 4.1A)None | 0.53A | 4n09D-3uqeA:26.4 | 4n09D-3uqeA:24.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vas | PUTATIVE ADENOSINEKINASE (Schistosomamansoni) |
PF00294(PfkB) | 10 | ASN A 14ASP A 18LEU A 40GLY A 63GLY A 64ASN A 68PHE A 169ASN A 298GLY A 299ASP A 302 | ADN A 401 ( 4.0A)ADN A 401 (-2.7A)NoneADN A 401 ( 3.8A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 ( 3.8A)ADN A 401 (-2.9A) | 0.54A | 4n09D-3vasA:47.4 | 4n09D-3vasA:30.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3vas | PUTATIVE ADENOSINEKINASE (Schistosomamansoni) |
PF00294(PfkB) | 6 | ASP A 18LEU A 138PHE A 169ASN A 298GLY A 299ASP A 302 | ADN A 401 (-2.7A)ADN A 401 (-4.9A)ADN A 401 (-3.7A)ADN A 401 (-3.7A)ADN A 401 ( 3.8A)ADN A 401 (-2.9A) | 1.46A | 4n09D-3vasA:47.4 | 4n09D-3vasA:30.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b98 | BETA-ALANINE--PYRUVATE TRANSAMINASE (Pseudomonasaeruginosa) |
PF00202(Aminotran_3) | 5 | LEU A 186GLY A 416GLY A 417ASN A 169GLY A 168 | None | 1.00A | 4n09D-4b98A:3.0 | 4n09D-4b98A:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e3a | SUGAR KINASE PROTEIN (Rhizobium etli) |
PF00294(PfkB) | 8 | ASN A 9ASP A 13LEU A 35GLY A 56GLY A 57ASN A 61GLY A 273ASP A 276 | ADN A 500 (-3.8A)ADN A 500 (-2.7A)NoneADN A 500 (-3.5A)ADN A 500 (-3.7A)ADN A 500 (-3.5A)ADN A 500 (-3.9A)ADN A 500 (-2.8A) | 0.55A | 4n09D-4e3aA:40.8 | 4n09D-4e3aA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e3a | SUGAR KINASE PROTEIN (Rhizobium etli) |
PF00294(PfkB) | 6 | ASN A 9LEU A 35GLY A 57ASN A 61GLY A 275ASP A 276 | ADN A 500 (-3.8A)NoneADN A 500 (-3.7A)ADN A 500 (-3.5A)NoneADN A 500 (-2.8A) | 1.20A | 4n09D-4e3aA:40.8 | 4n09D-4e3aA:25.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e84 | D-BETA-D-HEPTOSE7-PHOSPHATE KINASE (Burkholderiacenocepacia) |
PF00294(PfkB) | 5 | ASP A 29GLY A 58GLY A 59GLY A 267ASP A 270 | M7B A 502 (-2.9A)M7B A 502 (-3.4A)M7B A 502 (-3.6A)M7B A 502 (-3.7A)M7B A 502 (-3.1A) | 0.94A | 4n09D-4e84A:26.6 | 4n09D-4e84A:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4emd | 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE (Mycobacteroidesabscessus) |
PF00288(GHMP_kinases_N)PF08544(GHMP_kinases_C) | 5 | ASP A 117GLY A 114GLY A 113ALA A 49GLY A 68 | NoneSO4 A 402 (-3.4A)SO4 A 402 (-3.8A)NoneNone | 0.97A | 4n09D-4emdA:undetectable | 4n09D-4emdA:24.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gm6 | PFKB FAMILYCARBOHYDRATE KINASE (Listeria grayi) |
PF00294(PfkB) | 6 | LEU A 172GLY A 33GLY A 34ASN A 38GLY A 267ASP A 270 | NoneGOL A 401 ( 4.1A)GOL A 401 (-3.7A)GOL A 401 (-4.4A)GOL A 401 ( 4.5A)GOL A 401 (-3.0A) | 0.98A | 4n09D-4gm6A:29.3 | 4n09D-4gm6A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h1s | 5'-NUCLEOTIDASE (Homo sapiens) |
PF00149(Metallophos)PF02872(5_nucleotid_C) | 5 | GLY A 393GLY A 392ASN A 390GLY A 505ASP A 506 | None | 0.83A | 4n09D-4h1sA:undetectable | 4n09D-4h1sA:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jb3 | HALOACIDDEHALOGENASE-LIKEHYDROLASE (Bacteroidesthetaiotaomicron) |
PF13419(HAD_2) | 5 | ASP A 172LEU A 37GLY A 11GLY A 10ASN A 176 | NA A 301 (-2.8A)None NA A 301 ( 4.0A) NA A 301 (-4.4A)None | 0.92A | 4n09D-4jb3A:2.9 | 4n09D-4jb3A:21.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oh1 | L-IDITOL2-DEHYDROGENASE ([Clostridium]scindens) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 5 | LEU A 162GLY A 182GLY A 183ALA A 161GLY A 46 | NoneNoneNoneNoneOCS A 45 ( 2.4A) | 0.97A | 4n09D-4oh1A:5.6 | 4n09D-4oh1A:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oon | PENICILLIN-BINDINGPROTEIN 1A (Pseudomonasaeruginosa) |
PF00905(Transpeptidase)PF00912(Transgly)PF17092(PCB_OB) | 5 | LEU A 685GLY A 709GLY A 694ALA A 684GLY A 697 | NoneNoneNoneNone2U4 A 901 (-3.7A) | 0.99A | 4n09D-4oonA:undetectable | 4n09D-4oonA:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rlb | CARBAPENEM-ASSOCIATED RESISTANCE PROTEIN (Acinetobacterbaumannii) |
no annotation | 5 | LEU A 35GLY A 151ALA A 45PHE A 165GLY A 218 | None | 1.00A | 4n09D-4rlbA:undetectable | 4n09D-4rlbA:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uhm | OMEGA AMINOACID-PYRUVATEAMINOTRANSFERASE (Pseudomonas sp.) |
PF00202(Aminotran_3) | 5 | LEU A 186GLY A 416GLY A 417ASN A 169GLY A 168 | NoneNoneNone CL A1459 (-3.2A)None | 0.96A | 4n09D-4uhmA:2.7 | 4n09D-4uhmA:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uoz | BETA-GALACTOSIDASE (Bifidobacteriumanimalis) |
PF02449(Glyco_hydro_42)PF08532(Glyco_hydro_42M)PF08533(Glyco_hydro_42C) | 5 | LEU A 140GLY A 162ALA A 139ASN A 169GLY A 166 | None | 0.87A | 4n09D-4uozA:4.2 | 4n09D-4uozA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 6 | ASP A 11GLY A 29GLY A 30ASN A 34GLY A 246ASP A 249 | NoneNoneNoneNoneANP A 401 (-3.3A)ANP A 401 ( 4.3A) | 0.52A | 4n09D-4wjmA:29.9 | 4n09D-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 5 | GLY A 30ASN A 34ALA A 85GLY A 246ASP A 249 | NoneNoneNoneANP A 401 (-3.3A)ANP A 401 ( 4.3A) | 0.99A | 4n09D-4wjmA:29.9 | 4n09D-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wjm | RIBOKINASE:CARBOHYDRATE KINASE, PFKB (Brucellaabortus) |
PF00294(PfkB) | 5 | LEU A 162GLY A 29GLY A 30ASN A 34ASP A 249 | NoneNoneNoneNoneANP A 401 ( 4.3A) | 0.93A | 4n09D-4wjmA:29.9 | 4n09D-4wjmA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4x8f | RIBOKINASE (Vibrio cholerae) |
PF00294(PfkB) | 5 | ASP A 13GLY A 38GLY A 39ASN A 43ASP A 252 | None | 0.55A | 4n09D-4x8fA:29.7 | 4n09D-4x8fA:24.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z42 | UREASE SUBUNIT ALPHAUREASE SUBUNIT BETA (Yersiniaenterocolitica) |
PF00449(Urease_alpha)PF00699(Urease_beta)PF01979(Amidohydro_1) | 6 | ASN C 104ASP C 109LEU B 124GLY C 110ASN B 50GLY C 40 | None | 1.48A | 4n09D-4z42C:2.4 | 4n09D-4z42C:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5az4 | FLAGELLAR HOOKSUBUNIT PROTEIN (Campylobacterjejuni) |
PF07196(Flagellin_IN)PF07559(FlaE) | 6 | LEU A 296GLY A 343GLY A 345ASN A 340ALA A 316ASP A 347 | None | 1.49A | 4n09D-5az4A:undetectable | 4n09D-5az4A:18.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c41 | RIBOKINASE (Homo sapiens) |
PF00294(PfkB) | 6 | ASP A 27GLY A 52GLY A 53ASN A 57GLY A 266ASP A 269 | NoneNoneNoneNoneACP A 401 ( 4.1A) NA A 403 ( 4.7A) | 0.55A | 4n09D-5c41A:32.4 | 4n09D-5c41A:25.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5da0 | SULPHATE TRANSPORTER (Deinococcusgeothermalis) |
PF00916(Sulfate_transp)PF01740(STAS) | 5 | LEU A 35GLY A 298GLY A 72ALA A 305GLY A 68 | None | 0.98A | 4n09D-5da0A:undetectable | 4n09D-5da0A:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ey7 | FRUCTOKINASE (Vibrio cholerae) |
PF00294(PfkB) | 5 | ASP A 30GLY A 44GLY A 45ASN A 49ASP A 266 | None | 0.45A | 4n09D-5ey7A:31.1 | 4n09D-5ey7A:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ey7 | FRUCTOKINASE (Vibrio cholerae) |
PF00294(PfkB) | 5 | ASP A 30GLY A 45ASN A 49GLY A 263ASP A 266 | None | 0.82A | 4n09D-5ey7A:31.1 | 4n09D-5ey7A:23.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h7w | VENOM5'-NUCLEOTIDASE (Naja atra) |
no annotation | 5 | GLY A 393GLY A 392ASN A 390GLY A 506ASP A 507 | None | 0.86A | 4n09D-5h7wA:undetectable | 4n09D-5h7wA:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5h8y | SULFITE REDUCTASE[FERREDOXIN],CHLOROPLASTIC (Zea mays) |
PF01077(NIR_SIR)PF03460(NIR_SIR_ferr) | 5 | LEU A 497GLY A 543CYH A 494ALA A 496GLY A 553 | NoneSF4 A 701 (-4.4A)SF4 A 701 ( 2.2A)SF4 A 701 ( 3.9A)None | 0.91A | 4n09D-5h8yA:undetectable | 4n09D-5h8yA:20.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iof | SULPHATE TRANSPORTER (Deinococcusgeothermalis) |
PF00916(Sulfate_transp) | 5 | LEU A 35GLY A 298GLY A 72ALA A 305GLY A 68 | None | 0.98A | 4n09D-5iofA:undetectable | 4n09D-5iofA:23.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kgn | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Caenorhabditiselegans) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 5 | ASP A 426GLY A 38GLY A 469ALA A 484GLY A 89 | MN A 604 (-2.2A)NoneNoneNoneNone | 0.90A | 4n09D-5kgnA:3.3 | 4n09D-5kgnA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kva | CAFFEOYL-COAO-METHYLTRANSFERASE (Sorghum bicolor) |
PF01596(Methyltransf_3) | 5 | LEU A 115GLY A 197GLY A 198ALA A 94PHE A 173 | None | 1.00A | 4n09D-5kvaA:4.7 | 4n09D-5kvaA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o0j | ADP-DEPENDENTGLUCOKINASE (Pyrococcushorikoshii) |
no annotation | 5 | ASP A 37GLY A 114GLY A 115ALA A 204ASP A 443 | GLC A 503 (-2.7A)GLC A 503 (-3.5A)GLC A 503 (-3.7A)NoneGLC A 503 (-2.6A) | 0.79A | 4n09D-5o0jA:23.9 | 4n09D-5o0jA:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o0j | ADP-DEPENDENTGLUCOKINASE (Pyrococcushorikoshii) |
no annotation | 5 | ASP A 37LEU A 93GLY A 114GLY A 115ALA A 204 | GLC A 503 (-2.7A)NoneGLC A 503 (-3.5A)GLC A 503 (-3.7A)None | 0.59A | 4n09D-5o0jA:23.9 | 4n09D-5o0jA:13.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5od2 | BIFUNCTIONALADP-SPECIFICGLUCOKINASE/PHOSPHOFRUCTOKINASE (Methanocaldococcusjannaschii) |
no annotation | 5 | ASP A 28GLY A 106GLY A 107ALA A 201ASP A 442 | GLC A 501 (-2.7A)GLC A 501 (-3.2A)GLC A 501 (-3.7A)NoneGLC A 501 ( 2.6A) | 0.61A | 4n09D-5od2A:22.2 | 4n09D-5od2A:14.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5od2 | BIFUNCTIONALADP-SPECIFICGLUCOKINASE/PHOSPHOFRUCTOKINASE (Methanocaldococcusjannaschii) |
no annotation | 5 | ASP A 28GLY A 107ALA A 201GLY A 439ASP A 442 | GLC A 501 (-2.7A)GLC A 501 (-3.7A)NonePO4 A 504 (-3.1A)GLC A 501 ( 2.6A) | 0.90A | 4n09D-5od2A:22.2 | 4n09D-5od2A:14.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vdn | GLUTATHIONEOXIDOREDUCTASE (Yersinia pestis) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | GLY A 26GLY A 25ALA A 327ASN A 314GLY A 150 | NoneFAD A 502 (-3.6A)NoneNoneFAD A 502 (-3.3A) | 0.94A | 4n09D-5vdnA:3.4 | 4n09D-5vdnA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vdn | GLUTATHIONEOXIDOREDUCTASE (Yersinia pestis) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | LEU A 344GLY A 26ALA A 327ASN A 314GLY A 150 | NoneNoneNoneNoneFAD A 502 (-3.3A) | 0.99A | 4n09D-5vdnA:3.4 | 4n09D-5vdnA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x4j | UNCHARACTERIZEDPROTEIN (Pyrococcusfuriosus) |
no annotation | 5 | GLY A 138GLY A 136ALA A 41GLY A 164ASP A 165 | None ZN A 501 ( 4.8A)NoneNone ZN A 501 (-2.3A) | 0.96A | 4n09D-5x4jA:3.1 | 4n09D-5x4jA:12.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xb6 | UNCHARACTERIZEDPROTEIN YCJY (Escherichiacoli) |
no annotation | 5 | LEU A 199GLY A 45GLY A 44ALA A 202GLY A 119 | None | 0.99A | 4n09D-5xb6A:3.8 | 4n09D-5xb6A:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cw5 | RIBOKINASE (Cryptococcusneoformans) |
no annotation | 5 | ASP A 16GLY A 41GLY A 42ASN A 46ASP A 273 | GOL A 400 (-2.8A)GOL A 400 (-3.5A)GOL A 400 (-3.3A)GOL A 400 (-3.3A)None | 0.35A | 4n09D-6cw5A:31.7 | 4n09D-6cw5A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cw5 | RIBOKINASE (Cryptococcusneoformans) |
no annotation | 5 | ASP A 16GLY A 42ASN A 46GLY A 270ASP A 273 | GOL A 400 (-2.8A)GOL A 400 (-3.3A)GOL A 400 (-3.3A)NoneNone | 0.67A | 4n09D-6cw5A:31.7 | 4n09D-6cw5A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dcn | DELTA 2 CRYSTALLIN (Anasplatyrhynchos) |
PF00206(Lyase_1)PF14698(ASL_C2) | 4 | LEU A 182SER A 177LEU A 457LEU A 141 | None | 1.29A | 4n09D-1dcnA:undetectable | 4n09D-1dcnA:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ej6 | LAMBDA1 (Reovirus sp.) |
no annotation | 4 | CYH B 925LEU B 997SER B 517LEU B 987 | None | 1.33A | 4n09D-1ej6B:undetectable | 4n09D-1ej6B:15.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f2r | INHIBITOR OFCASPASE-ACTIVATEDDNASE (Mus musculus) |
PF02017(CIDE-N) | 4 | LEU I 42SER I 44LEU I 49LEU I 61 | None | 1.30A | 4n09D-1f2rI:undetectable | 4n09D-1f2rI:14.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fuu | YEAST INITIATIONFACTOR 4A (Saccharomycescerevisiae) |
PF00270(DEAD) | 4 | CYH A 123LEU A 93LEU A 189LEU A 95 | None | 1.04A | 4n09D-1fuuA:4.2 | 4n09D-1fuuA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gqp | DOC1/APC10 (Saccharomycescerevisiae) |
PF03256(ANAPC10) | 4 | LEU A 156SER A 126LEU A 234LEU A 247 | None | 1.26A | 4n09D-1gqpA:undetectable | 4n09D-1gqpA:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hkk | CHITOTRIOSIDASE-1 (Homo sapiens) |
PF00704(Glyco_hydro_18) | 4 | LEU A 127SER A 122LEU A 162LEU A 94 | None | 1.22A | 4n09D-1hkkA:3.6 | 4n09D-1hkkA:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i0a | DELTA CRYSTALLIN I (Meleagrisgallopavo) |
PF00206(Lyase_1)PF14698(ASL_C2) | 4 | LEU A 180SER A 175LEU A 455LEU A 139 | None | 1.33A | 4n09D-1i0aA:undetectable | 4n09D-1i0aA:23.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jl5 | OUTER PROTEIN YOPM (Yersinia pestis) |
PF12468(TTSSLRR) | 4 | LEU A1109SER A1115LEU A1093LEU A1106 | None | 1.19A | 4n09D-1jl5A:undetectable | 4n09D-1jl5A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jl5 | OUTER PROTEIN YOPM (Yersinia pestis) |
PF12468(TTSSLRR) | 4 | LEU A1136SER A1139LEU A1117LEU A1126 | None | 1.25A | 4n09D-1jl5A:undetectable | 4n09D-1jl5A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jl5 | OUTER PROTEIN YOPM (Yersinia pestis) |
PF12468(TTSSLRR) | 4 | LEU A1213SER A1219LEU A1197LEU A1210 | None | 1.27A | 4n09D-1jl5A:undetectable | 4n09D-1jl5A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k1b | B-CELL LYMPHOMA3-ENCODED PROTEIN (Homo sapiens) |
PF00023(Ank)PF12796(Ank_2) | 4 | LEU A 305SER A 307LEU A 316LEU A 350 | None | 1.18A | 4n09D-1k1bA:undetectable | 4n09D-1k1bA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ox4 | IMIDAZOLE GLYCEROLPHOSPHATE SYNTHASEHISHF (Saccharomycescerevisiae) |
PF00117(GATase)PF00977(His_biosynth) | 4 | LEU B 468SER B 402LEU B 454LEU B 484 | None | 1.33A | 4n09D-1ox4B:2.3 | 4n09D-1ox4B:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pdz | ENOLASE (Homarusgammarus) |
PF00113(Enolase_C)PF03952(Enolase_N) | 4 | LEU A 144SER A 176LEU A 412LEU A 418 | None | 1.24A | 4n09D-1pdzA:undetectable | 4n09D-1pdzA:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qva | INITIATION FACTOR 4A (Saccharomycescerevisiae) |
PF00270(DEAD) | 4 | CYH A 123LEU A 93LEU A 189LEU A 95 | None | 1.13A | 4n09D-1qvaA:4.0 | 4n09D-1qvaA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sgj | CITRATE LYASE, BETASUBUNIT (Deinococcusradiodurans) |
PF03328(HpcH_HpaI) | 4 | LEU A 190SER A 10LEU A 7LEU A 125 | None | 0.95A | 4n09D-1sgjA:2.7 | 4n09D-1sgjA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1smt | TRANSCRIPTIONALREPRESSOR SMTB (Synechococcuselongatus) |
PF01022(HTH_5) | 4 | LEU A 88SER A 82LEU A 51LEU A 43 | None | 1.32A | 4n09D-1smtA:undetectable | 4n09D-1smtA:18.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wb0 | CHITOTRIOSIDASE 1 (Homo sapiens) |
PF00704(Glyco_hydro_18) | 4 | LEU A 127SER A 122LEU A 162LEU A 94 | None | 1.23A | 4n09D-1wb0A:2.4 | 4n09D-1wb0A:24.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zkl | HIGH-AFFINITYCAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 7A (Homo sapiens) |
PF00233(PDEase_I) | 4 | LEU A 198SER A 172LEU A 177LEU A 194 | None | 1.17A | 4n09D-1zklA:undetectable | 4n09D-1zklA:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b7h | HEMOGLOBIN ALPHACHAIN (Cerdocyon thous) |
PF00042(Globin) | 4 | LEU A 76SER A 133LEU A 66LEU A 2 | NoneHEM A 200 ( 4.8A)HEM A 200 ( 4.6A)None | 0.91A | 4n09D-2b7hA:undetectable | 4n09D-2b7hA:19.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bex | RIBONUCLEASEINHIBITOR (Homo sapiens) |
PF13516(LRR_6) | 4 | CYH A 304LEU A 342LEU A 374LEU A 317 | None | 1.24A | 4n09D-2bexA:undetectable | 4n09D-2bexA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bnh | RIBONUCLEASEINHIBITOR (Sus scrofa) |
PF13516(LRR_6) | 4 | CYH A 300LEU A 338LEU A 370LEU A 313 | None | 1.21A | 4n09D-2bnhA:undetectable | 4n09D-2bnhA:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dw6 | BLL6730 PROTEIN (Bradyrhizobiumjaponicum) |
PF13378(MR_MLE_C) | 4 | LEU A 289SER A 315LEU A 306LEU A 277 | None | 1.30A | 4n09D-2dw6A:undetectable | 4n09D-2dw6A:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eig | LECTIN (Lotustetragonolobus) |
PF00139(Lectin_legB) | 4 | LEU A 192SER A 167LEU A 227LEU A 86 | None | 1.25A | 4n09D-2eigA:undetectable | 4n09D-2eigA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g4r | MOLYBDOPTERINBIOSYNTHESIS MOGPROTEIN (Mycobacteriumtuberculosis) |
PF00994(MoCF_biosynth) | 4 | CYH A 24LEU A 128SER A 131LEU A 139 | None | 1.32A | 4n09D-2g4rA:undetectable | 4n09D-2g4rA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hes | YDR267CP (Saccharomycescerevisiae) |
PF00400(WD40) | 4 | LEU X 27SER X 40LEU X 10LEU X 304 | None | 1.33A | 4n09D-2hesX:undetectable | 4n09D-2hesX:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i3o | GAMMA-GLUTAMYLTRANSFERASE RELATEDPROTEIN (Thermoplasmaacidophilum) |
PF01019(G_glu_transpept) | 4 | LEU A 409SER A 411LEU A 439LEU A 425 | None | 1.31A | 4n09D-2i3oA:undetectable | 4n09D-2i3oA:22.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ilx | 2',3'-CYCLIC-NUCLEOTIDE3'-PHOSPHODIESTERASE (Rattusnorvegicus) |
PF05881(CNPase) | 4 | LEU A 70SER A 18LEU A 104LEU A 153 | None | 1.29A | 4n09D-2ilxA:undetectable | 4n09D-2ilxA:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p5x | N-ACETYLSEROTONINO-METHYLTRANSFERASE-LIKE PROTEIN (Homo sapiens) |
PF02545(Maf) | 4 | CYH A 205LEU A 33LEU A 17LEU A 10 | None | 1.16A | 4n09D-2p5xA:undetectable | 4n09D-2p5xA:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pyf | T-CELL RECEPTOR,BETA CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | LEU B 108SER B 106LEU B 74LEU B 11 | None | 1.25A | 4n09D-2pyfB:undetectable | 4n09D-2pyfB:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rt5 | MSX2-INTERACTINGPROTEIN (Homo sapiens) |
PF07744(SPOC) | 4 | LEU A3642SER A3637LEU A3647LEU A3575 | None | 1.25A | 4n09D-2rt5A:undetectable | 4n09D-2rt5A:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2uuu | ALKYLDIHYDROXYACETONEPHOSPHATE SYNTHASE (Dictyosteliumdiscoideum) |
PF01565(FAD_binding_4)PF02913(FAD-oxidase_C) | 4 | LEU A 143SER A 191LEU A 146LEU A 101 | None | 1.33A | 4n09D-2uuuA:undetectable | 4n09D-2uuuA:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wui | TRANSCRIPTIONALREGULATOR (Pseudomonasaeruginosa) |
PF00440(TetR_N)PF08361(TetR_C_2) | 4 | LEU A 196SER A 198LEU A 166LEU A 85 | None | 1.33A | 4n09D-2wuiA:undetectable | 4n09D-2wuiA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xxs | PROTEIN MXIG (Shigellaflexneri) |
PF09480(PrgH) | 4 | CYH A 72LEU A 100SER A 86LEU A 23 | None | 1.22A | 4n09D-2xxsA:undetectable | 4n09D-2xxsA:14.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zf3 | HYPOTHETICAL PROTEINVIOE (Chromobacteriumviolaceum) |
no annotation | 4 | CYH A 35SER A 15LEU A 158LEU A 110 | None | 1.23A | 4n09D-2zf3A:undetectable | 4n09D-2zf3A:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3e4b | ALGK (Pseudomonasfluorescens) |
no annotation | 4 | LEU A 223SER A 218LEU A 240LEU A 199 | None | 1.21A | 4n09D-3e4bA:undetectable | 4n09D-3e4bA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3efb | PROBABLE SOR-OPERONREGULATOR (Shigellaflexneri) |
PF04198(Sugar-bind) | 4 | LEU A 263SER A 258LEU A 15LEU A 253 | None | 1.22A | 4n09D-3efbA:3.8 | 4n09D-3efbA:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3evz | METHYLTRANSFERASE (Pyrococcusfuriosus) |
PF05175(MTS) | 4 | LEU A 202SER A 239LEU A 211LEU A 187 | None | 1.25A | 4n09D-3evzA:4.8 | 4n09D-3evzA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g7k | 3-METHYLITACONATEISOMERASE (Eubacteriumbarkeri) |
PF04303(PrpF) | 4 | LEU A 63SER A 61LEU A 39LEU A 22 | None | 1.23A | 4n09D-3g7kA:undetectable | 4n09D-3g7kA:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hdj | PROBABLE ORNITHINECYCLODEAMINASE (Bordetellapertussis) |
PF02423(OCD_Mu_crystall) | 4 | CYH A 165LEU A 143LEU A 147LEU A 137 | None | 1.30A | 4n09D-3hdjA:4.6 | 4n09D-3hdjA:23.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hsk | ASPARTATE-SEMIALDEHYDE DEHYDROGENASE (Candidaalbicans) |
PF01118(Semialdhyde_dh)PF02774(Semialdhyde_dhC) | 4 | LEU A 102SER A 96LEU A 9LEU A 76 | None | 1.31A | 4n09D-3hskA:3.8 | 4n09D-3hskA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ijf | CYTIDINE DEAMINASE (Mycobacteriumtuberculosis) |
PF00383(dCMP_cyt_deam_1) | 4 | CYH X 59LEU X 96LEU X 119LEU X 76 | None | 1.33A | 4n09D-3ijfX:undetectable | 4n09D-3ijfX:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jb9 | U2 SMALL NUCLEARRIBONUCLEOPROTEIN A' (Schizosaccharomycespombe) |
PF01423(LSM) | 4 | LEU j 92SER j 118LEU j 69LEU j 56 | None | 1.05A | 4n09D-3jb9j:undetectable | 4n09D-3jb9j:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kl9 | GLUTAMYLAMINOPEPTIDASE (Streptococcuspneumoniae) |
PF05343(Peptidase_M42) | 4 | LEU A 207SER A 209LEU A 62LEU A 192 | None | 1.28A | 4n09D-3kl9A:2.4 | 4n09D-3kl9A:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lfk | MARR LIKE PROTEIN,TVG0766549 (Thermoplasmavolcanium) |
no annotation | 4 | LEU A 89SER A 91LEU A 77LEU A 39 | None | 1.16A | 4n09D-3lfkA:undetectable | 4n09D-3lfkA:17.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3loo | ANOPHELES GAMBIAEADENOSINE KINASE (Anophelesgambiae) |
PF00294(PfkB) | 4 | LEU A 16SER A 65LEU A 133LEU A 137 | B4P A 349 (-4.7A) CL A 351 ( 4.6A)B4P A 349 (-4.5A)None | 0.47A | 4n09D-3looA:47.9 | 4n09D-3looA:36.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ly9 | TRANSCRIPTIONALACTIVATOR CADC (Escherichiacoli) |
no annotation | 4 | LEU A 307SER A 311LEU A 231LEU A 326 | None | 1.26A | 4n09D-3ly9A:undetectable | 4n09D-3ly9A:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mn8 | LP15968P (Drosophilamelanogaster) |
PF00246(Peptidase_M14)PF13620(CarboxypepD_reg) | 4 | CYH A 299SER A 213LEU A 332LEU A 377 | None | 1.27A | 4n09D-3mn8A:2.4 | 4n09D-3mn8A:22.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mn8 | LP15968P (Drosophilamelanogaster) |
PF00246(Peptidase_M14)PF13620(CarboxypepD_reg) | 4 | LEU A 251SER A 213LEU A 332LEU A 377 | None | 1.13A | 4n09D-3mn8A:2.4 | 4n09D-3mn8A:22.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nwn | KINESIN-LIKE PROTEINKIF9 (Homo sapiens) |
PF00225(Kinesin) | 4 | CYH A 295LEU A 275SER A 271LEU A 301 | None | 1.14A | 4n09D-3nwnA:undetectable | 4n09D-3nwnA:20.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3otx | ADENOSINE KINASE,PUTATIVE (Trypanosomabrucei) |
PF00294(PfkB) | 5 | CYH A 12LEU A 15SER A 64LEU A 134LEU A 138 | AP5 A 346 (-3.6A)AP5 A 346 (-4.4A) NA A 347 (-4.8A)AP5 A 346 ( 4.4A)None | 0.26A | 4n09D-3otxA:58.3 | 4n09D-3otxA:99.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s30 | HYPOTHETICALGLYCOSIDE HYDROLASE (Bacteroidesvulgatus) |
PF13201(PCMD) | 4 | LEU A 150SER A 163LEU A 160LEU A 195 | None | 1.25A | 4n09D-3s30A:undetectable | 4n09D-3s30A:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s5k | FALCILYSIN (Plasmodiumfalciparum) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C)PF08367(M16C_assoc) | 4 | LEU A1015SER A1060LEU A1022LEU A1156 | None | 1.19A | 4n09D-3s5kA:undetectable | 4n09D-3s5kA:13.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tsr | RIBONUCLEASEINHIBITOR (Mus musculus) |
PF13516(LRR_6) | 4 | CYH E 300LEU E 338LEU E 370LEU E 313 | None | 1.19A | 4n09D-3tsrE:undetectable | 4n09D-3tsrE:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4d3c | SFN68 FAB (Oryctolaguscuniculus) |
PF07654(C1-set)PF07686(V-set) | 4 | LEU L 2SER L 28LEU L 32LEU L 4 | None | 1.12A | 4n09D-4d3cL:undetectable | 4n09D-4d3cL:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ewj | ENOLASE 2 (Streptococcussuis) |
PF00113(Enolase_C)PF03952(Enolase_N) | 4 | LEU A 142SER A 174LEU A 412LEU A 418 | None | 1.27A | 4n09D-4ewjA:undetectable | 4n09D-4ewjA:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ft2 | DNA(CYTOSINE-5)-METHYLTRANSFERASE 1 (Zea mays) |
PF00145(DNA_methylase)PF00385(Chromo)PF01426(BAH) | 4 | CYH A 512SER A 354LEU A 359LEU A 865 | None | 0.86A | 4n09D-4ft2A:5.6 | 4n09D-4ft2A:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k37 | ANAEROBICSULFATASE-MATURATINGENZYME (Clostridiumperfringens) |
PF04055(Radical_SAM)PF13186(SPASM)PF13353(Fer4_12) | 4 | LEU A 112SER A 107LEU A 152LEU A 97 | None | 1.04A | 4n09D-4k37A:2.5 | 4n09D-4k37A:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kpp | PUTATIVEUNCHARACTERIZEDPROTEIN (Archaeoglobusfulgidus) |
PF01699(Na_Ca_ex) | 4 | LEU A 145SER A 280LEU A 140LEU A 331 | None | 1.29A | 4n09D-4kppA:undetectable | 4n09D-4kppA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lry | PTS-DEPENDENTDIHYDROXYACETONEKINASE,DIHYDROXYACETONE-BINDING SUBUNIT DHAK (Escherichiacoli) |
PF02733(Dak1) | 4 | CYH A 304LEU A 272LEU A 333LEU A 242 | None | 1.10A | 4n09D-4lryA:2.8 | 4n09D-4lryA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m0m | PUTATIVEUNCHARACTERIZEDPROTEIN (Legionellapneumophila) |
no annotation | 4 | LEU A 438SER A 440LEU A 464LEU A 482 | None | 1.31A | 4n09D-4m0mA:4.9 | 4n09D-4m0mA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mdr | AP-4 COMPLEX SUBUNITMU-1 (Homo sapiens) |
PF00928(Adap_comp_sub) | 4 | LEU A 315SER A 301LEU A 377LEU A 334 | None | 1.11A | 4n09D-4mdrA:undetectable | 4n09D-4mdrA:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mhp | GLUTAMINYL CYCLASE,PUTATIVE (Ixodesscapularis) |
PF04389(Peptidase_M28) | 4 | LEU A 163SER A 158LEU A 88LEU A 175 | None | 1.07A | 4n09D-4mhpA:undetectable | 4n09D-4mhpA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nzk | UNCHARACTERIZEDPROTEIN ([Eubacterium]siraeum) |
PF14286(DHHW) | 4 | CYH A 209LEU A 314SER A 332LEU A 361 | None | 1.27A | 4n09D-4nzkA:2.5 | 4n09D-4nzkA:21.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4peq | RIBONUCLEASE/ANGIOGENIN INHIBITOR 1 (Bos taurus) |
PF13516(LRR_6) | 4 | CYH B 300LEU B 338LEU B 370LEU B 313 | None | 1.26A | 4n09D-4peqB:undetectable | 4n09D-4peqB:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4peq | RIBONUCLEASE/ANGIOGENIN INHIBITOR 1 (Bos taurus) |
PF13516(LRR_6) | 4 | CYH B 324LEU B 343LEU B 313LEU B 356 | None | 1.26A | 4n09D-4peqB:undetectable | 4n09D-4peqB:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4peq | RIBONUCLEASE/ANGIOGENIN INHIBITOR 1 (Bos taurus) |
PF13516(LRR_6) | 4 | CYH B 357LEU B 395LEU B 427LEU B 370 | None | 1.26A | 4n09D-4peqB:undetectable | 4n09D-4peqB:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4per | RIBONUCLEASEINHIBITOR (Gallus gallus) |
PF13516(LRR_6) | 4 | CYH A 300LEU A 338LEU A 370LEU A 313 | None | 1.30A | 4n09D-4perA:undetectable | 4n09D-4perA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4psp | ALPHA-FUCOSIDASEGH29 (Fusariumgraminearum) |
PF01120(Alpha_L_fucos)PF16757(Fucosidase_C) | 4 | LEU A 198SER A 190LEU A 195LEU A 206 | None | 1.04A | 4n09D-4pspA:2.9 | 4n09D-4pspA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pxh | PEPTIDE SYNTHETASE (Streptomycessp. Acta 2897) |
PF00550(PP-binding) | 4 | LEU B 60SER B 50LEU B 62LEU B 74 | None | 1.07A | 4n09D-4pxhB:undetectable | 4n09D-4pxhB:13.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qdg | PUTATIVE ADHESIN (Bacteroidesthetaiotaomicron) |
PF08842(Mfa2) | 4 | LEU A 97SER A 44LEU A 161LEU A 68 | None | 1.22A | 4n09D-4qdgA:undetectable | 4n09D-4qdgA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qdn | FLAGELLAR PROTEINFLGJ [PEPTIDOGLYCANHYDROLASE] (Thermotogamaritima) |
PF01832(Glucosaminidase) | 4 | LEU A 27SER A 12LEU A 46LEU A 89 | None | 1.05A | 4n09D-4qdnA:undetectable | 4n09D-4qdnA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qfv | ANK-N5C-281 (syntheticconstruct) |
PF00023(Ank)PF12796(Ank_2)PF13637(Ank_4) | 4 | LEU A 174SER A 176LEU A 185LEU A 222 | None | 1.24A | 4n09D-4qfvA:undetectable | 4n09D-4qfvA:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4tlv | ADP-RIBOSYLATINGTOXIN CARDS (Mycoplasmapneumoniae) |
PF02917(Pertussis_S1) | 4 | LEU A 38SER A 225LEU A 123LEU A 260 | None | 1.27A | 4n09D-4tlvA:undetectable | 4n09D-4tlvA:19.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w8j | PESTICIDAL CRYSTALPROTEIN CRY1AC (Bacillusthuringiensis) |
PF00555(Endotoxin_M)PF03944(Endotoxin_C)PF03945(Endotoxin_N) | 4 | LEU A 656SER A 669LEU A 662LEU A 618 | None | 1.09A | 4n09D-4w8jA:undetectable | 4n09D-4w8jA:14.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yac | CALPHA-DEHYDROGENASE (Sphingobium sp.SYK-6) |
PF00106(adh_short) | 4 | LEU A 185SER A 144LEU A 250LEU A 234 | None | 0.85A | 4n09D-4yacA:7.8 | 4n09D-4yacA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z17 | ENOLASE (Chloroflexusaurantiacus) |
PF00113(Enolase_C)PF03952(Enolase_N) | 4 | LEU A 143SER A 175LEU A 406LEU A 412 | None | 1.22A | 4n09D-4z17A:undetectable | 4n09D-4z17A:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z61 | PHYTOSULFOKINERECEPTOR 1 (Daucus carota) |
PF00560(LRR_1)PF13855(LRR_8) | 4 | LEU A 451SER A 446LEU A 469LEU A 430 | None | 1.24A | 4n09D-4z61A:undetectable | 4n09D-4z61A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zke | SUPERKILLER PROTEIN7 (Saccharomycescerevisiae) |
PF00009(GTP_EFTU) | 4 | LEU A 687SER A 697LEU A 704LEU A 674 | LEU A 687 ( 0.6A)SER A 697 ( 0.0A)LEU A 704 ( 0.6A)LEU A 674 ( 0.6A) | 1.10A | 4n09D-4zkeA:3.7 | 4n09D-4zkeA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zoq | INTRACELLULAR SERINEPROTEASE (Bacilluslicheniformis) |
PF00082(Peptidase_S8) | 4 | LEU I 345SER I 370LEU I 377LEU I 330 | None | 1.02A | 4n09D-4zoqI:4.9 | 4n09D-4zoqI:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5by7 | 3-OXOACYL-ACPSYNTHASE III (Verrucosisporamaris) |
PF08541(ACP_syn_III_C)PF08545(ACP_syn_III) | 4 | LEU A 167SER A -10LEU A 127LEU A 111 | None | 1.13A | 4n09D-5by7A:undetectable | 4n09D-5by7A:23.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fyq | NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-2 (Homo sapiens) |
PF02146(SIR2) | 4 | CYH A 148LEU A 258LEU A 284LEU A 331 | None | 1.27A | 4n09D-5fyqA:5.8 | 4n09D-5fyqA:22.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hsg | PUTATIVE ABCTRANSPORTER,NUCLEOTIDEBINDING/ATPASEPROTEIN (Klebsiellapneumoniae) |
PF13407(Peripla_BP_4) | 4 | LEU A 315SER A 311LEU A 252LEU A 49 | None | 1.03A | 4n09D-5hsgA:5.5 | 4n09D-5hsgA:24.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j04 | ENOLASE (Synechococcuselongatus) |
PF00113(Enolase_C)PF03952(Enolase_N) | 4 | LEU A 146SER A 178LEU A 407LEU A 413 | None | 1.32A | 4n09D-5j04A:undetectable | 4n09D-5j04A:23.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jpw | DYNEIN LIGHT CHAINTCTEX-TYPE1,CYTOPLASMIC DYNEIN1 INTERMEDIATE CHAIN2 (Homo sapiens) |
PF03645(Tctex-1)PF11540(Dynein_IC2) | 4 | CYH A 95LEU A 56SER A 20LEU A 53 | None | 1.19A | 4n09D-5jpwA:undetectable | 4n09D-5jpwA:16.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ks8 | PYRUVATE CARBOXYLASESUBUNIT BETA (Methylobacillusflagellatus) |
PF00364(Biotin_lipoyl)PF00682(HMGL-like)PF02436(PYC_OADA) | 4 | LEU C 73SER C 33LEU C 29LEU C 43 | None | 1.27A | 4n09D-5ks8C:2.1 | 4n09D-5ks8C:19.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n2s | SOLUBLE CYTOCHROMEB562,ADENOSINERECEPTOR A1 (Escherichiacoli;Homo sapiens) |
PF00001(7tm_1)PF07361(Cytochrom_B562) | 4 | LEU A1156SER A1386LEU A1195LEU A1203 | None | 1.17A | 4n09D-5n2sA:undetectable | 4n09D-5n2sA:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5opq | 3,6-ANHYDRO-D-GALACTOSIDASE (Zobelliagalactanivorans) |
no annotation | 4 | LEU A 418SER A 420LEU A 512LEU A 333 | None | 0.79A | 4n09D-5opqA:undetectable | 4n09D-5opqA:12.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oqr | CONDENSIN COMPLEXSUBUNIT 3 (Schizosaccharomycespombe) |
no annotation | 4 | LEU A 385SER A 387LEU A 408LEU A 422 | None | 0.95A | 4n09D-5oqrA:undetectable | 4n09D-5oqrA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tc1 | MATURATION PROTEIN (Escherichiavirus MS2) |
PF03863(Phage_mat-A) | 4 | LEU M 65SER M 100LEU M 104LEU M 111 | None | 1.18A | 4n09D-5tc1M:undetectable | 4n09D-5tc1M:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u30 | CRISPR-ASSOCIATEDENDONUCLEASE C2C1 (Alicyclobacillusacidoterrestris) |
no annotation | 4 | LEU A 847SER A 568LEU A 844LEU A 879 | None | 1.22A | 4n09D-5u30A:undetectable | 4n09D-5u30A:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ul4 | OXSB PROTEIN (Bacillusmegaterium) |
PF02310(B12-binding) | 4 | LEU A 541SER A 594LEU A 486LEU A 640 | EDO A 814 (-4.8A)NoneNoneNone | 1.27A | 4n09D-5ul4A:5.8 | 4n09D-5ul4A:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux5 | BIFUNCTIONAL PROTEINPROLINE UTILIZATIONA (PUTA) (Corynebacteriumfreiburgense) |
PF00171(Aldedh)PF01619(Pro_dh) | 4 | LEU A 169SER A 190LEU A 207LEU A 214 | None | 1.09A | 4n09D-5ux5A:undetectable | 4n09D-5ux5A:15.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v7i | SERINEHYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL (Homo sapiens) |
no annotation | 4 | LEU A 164SER A 226LEU A 166LEU A 197 | NoneLLP A 280 (-3.4A)8Z1 A 601 (-4.7A)None | 1.14A | 4n09D-5v7iA:4.7 | 4n09D-5v7iA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wde | KINESIN-LIKE PROTEINKIFC3 (Homo sapiens) |
PF00225(Kinesin) | 4 | CYH A 523SER A 732LEU A 606LEU A 725 | NoneUNX A 932 ( 2.7A)NoneNone | 1.24A | 4n09D-5wdeA:undetectable | 4n09D-5wdeA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x41 | COBALT ABCTRANSPORTERATP-BINDING PROTEIN (Rhodobactercapsulatus) |
PF00005(ABC_tran) | 4 | LEU A 37SER A 196LEU A 202LEU A 239 | None | 0.84A | 4n09D-5x41A:undetectable | 4n09D-5x41A:23.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c54 | NUCLEOPROTEIN (Zaireebolavirus) |
no annotation | 4 | LEU A 74SER A 72LEU A 209LEU A 203 | None | 0.96A | 4n09D-6c54A:undetectable | 4n09D-6c54A:14.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ccz | SERINEHYDROXYMETHYLTRANSFERASE (Medicagotruncatula) |
no annotation | 4 | LEU A 202SER A 264LEU A 204LEU A 235 | NoneACT A 612 (-2.7A)NoneNone | 1.08A | 4n09D-6cczA:undetectable | 4n09D-6cczA:12.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cfw | MONOVALENT CATION/H+ANTIPORTER SUBUNIT BMONOVALENT CATION/H+ANTIPORTER SUBUNIT FMONOVALENT CATION/H+ANTIPORTER SUBUNIT G (Pyrococcusfuriosus) |
no annotation | 4 | LEU B 66SER B 68LEU C 83LEU F 16 | None | 1.03A | 4n09D-6cfwB:undetectable | 4n09D-6cfwB:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ez8 | HUNTINGTIN (Homo sapiens) |
no annotation | 4 | LEU A1267SER A1271LEU A1141LEU A1293 | None | 1.24A | 4n09D-6ez8A:undetectable | 4n09D-6ez8A:8.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g2j | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Mus musculus) |
no annotation | 4 | LEU M 106SER M 101LEU M 73LEU M 235 | None3PE M 505 ( 3.8A)NoneNone | 0.88A | 4n09D-6g2jM:undetectable | 4n09D-6g2jM:11.90 |